Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes

Oxidative Stress Levels in Myelodysplastic Syndrome Patients: Their Relationship to Serum Ferritin and Haemoglobin Values

(2013) K Saigo et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox

(2012) Shohei Kikuchi et al.   FREE RADICAL BIOLOGY AND MEDICINE

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes

(2012) N. Gattermann et al.   HAEMATOLOGICA

Iron overload in MDS—pathophysiology, diagnosis, and complications

(2010) Norbert Gattermann et al.   ANNALS OF HEMATOLOGY

Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes

(2010) H. Ghoti et al.   HAEMATOLOGICA

Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?

(2009) V. Pullarkat   BLOOD

Body iron metabolism and pathophysiology of iron overload

(2008) Yutaka Kohgo et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY